dermatology News
-
New dermatology asset acquisition
Botanix has today announced acquisition of a novel dermatology asset known as Sofpironium Bromide, which has been developed to treat primary axillary hyperhidrosis – a medical condition which results in excessive underarm sweating. Sofpironium Bromide is the first and only new chemical entity developed for primary axillary hyperhidrosis, and this product is primed for market following ...
-
MIMS Learning Dermatology dedicates issue to skin of colour
Today Monthly Index of Medical Specialities (MIMS) announced its biannual medical publication MIMS Learning Dermatology is dedicating its first issue of 2021 to dermatology for skin of colour, a topic that is overlooked in medical education in the UK. “The UK is diverse and it is important our content and education resources reflect this. Our readers – dermatologists, GPs and ...
-
4th Edition of International Conference on Dermatology and Cosmetology
Magnus Group gladly invites you to attend its HYBRID EVENT “4th Edition of International Conference on Dermatology and Cosmetology” (IDC 2023) slated during May 24-25, 2023 at Tokyo, Japan. The conference deliberations will be on the theme “Revolutionizing Skin Care Through Advances in Dermatology and Cosmetology” Dermatology Conferences not only offer a ton of ...
-
Almirall and etherna enter into a multi-target alliance to develop mRNA-based therapies in medical dermatology
The multi-target research and development partnership will focus on severe skin diseases The collaboration leverages etherna’s proprietary mRNA and lipid nanoparticle (LNP) technology with Almirall’s expertise in the dermatology space In addition to upfront and technology access payments, etherna is eligible to receive €300 million in development and commercial ...
By eTheRNA
-
Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022 American Society of Laser Medicine and Surgery Annual Conference
Oral podium presentation highlights new long-term clinical results to clear Sebaceous Hyperplasia (SH) with high efficacy, continued improvement and good cosmesis Poster presents successful first case report of NPS procedure for recalcitrant HPV-related dermatosis on the lips Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System ...
-
Dr David Dantzker to present Origin’s plasma-generated Nitric Oxide to the MEIDAM dermatology conference in Dubai on September 21, 2019
Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that Dr. David Dantzker, Vice Chairman and Chief Medical Officer of Origin, and former Chairman of the American Board of Internal Medicine, would be presenting Origin’s plasma-generated Nitric Oxide technology to The 4th Middle East International Dermatology & Aesthetic Medicine Conference & Exhibition ...
By Origin, Inc
-
Symberix CEO Presents at Translational Microbiome Conference
Dr. Ward Peterson delivered a presentation entitled “When Good Bugs Do Bad Things: Targeting the Microbiome to Make Better Human Genome-Targeted Drugs” at the annual Translational Microbiome Conference on May 14, 2015 in Boston. The Conference focused on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make ...
-
RECELL System to be Highlighted at Upcoming Music City SCALE Multidisciplinary Dermatology Meeting
AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that a discussion on the RECELL System will be held during the Symposium for Cosmetic Advances & Laser Education (SCALE) multidisciplinary ...
-
The Use of Infrared Coagulation in Hair Transplant and Scalp Reduction Surgery
The infrared coagulator, a spin off of laser technology, has been used for more than a decade, first in Europe and then in the United States, for the in-office elimination offlrst and second degree hemorrhoids. Even more recently, it has been employed in the treatment and removal of unwanted tattoos. This device has been FDA approved for both anorectal and dermatologic applications. Within the ...
-
BiomX Announces Agreement with Maruho Co., Ltd. for Atopic Dermatitis Product Candidate BX005
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage cocktails that target specific pathogenic bacteria, announced today that it has entered into an agreement granting Maruho Co. Ltd., a leading dermatology-focused pharmaceutical company in Japan, a right of first offer to license ...
By BiomX
-
DERMAGO Group to expand its patent portfolio by acquiring the patents for the manufacture of the pharmaceutical agent Polyphenon® E from Mitsui Norin Co,Ltd.
DERMAGO Group (“DERMAGO”), announced today that it has acquired with immediate effect all patents regarding the manufacture of the pharmaceutical ingredient Polyphenon® E, a defined extract from green tea leaves, from the Japanese patent holder Mitsui Norin. Synonyms for “Polyphenon® E” are “defined extract from green tea leaves” and ...
-
Cabaletta Bio Announces Presentation of Preclinical Data Supporting PLA2R-CAART as a Potential Precision Therapy for Antigen-Specific B Cell Depletion in PLA2R Membranous Nephropathy at ASN Kidney Week 2021
PHILADELPHIA, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that data from in vitro studies supporting the early preclinical validation of PLA2R-Chimeric AutoAntibody Receptor T (CAART) cell ...
-
Improving the Patient Experience: Before, During, and After Office Procedures
Improving dermatology patients’ experience during dermatology procedures means more than simply providing top-notch aesthetic treatment. It requires thoughtful interactions that address every aspect of the patient's visit including their physical comfort, emotional state, and socioeconomic status. Patients increasingly choose healthcare providers who can respond to their specific needs. ...
-
How Small Adjustments to In-Office Dermatology Wound Care Can Affect the Bottom Line
The medical field uses advanced technology in all facets of daily operations. Patient intake forms, record keeping, communication portals, invoicing, and of course, procedures are enhanced by technological advances. Those advances are now shaping dermatology wound care too. Besides improved patient experience and clinical outcomes, technological advances can also positively affect a ...
-
Zerigo Health Raises $43M in Series B Funding
San Diego, CA, October 21, 2021 –Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced a $43 million Series B investment led by 7wireVentures, joined by General Catalyst, Dragoneer, Cigna Ventures, Leverage Health Solutions, and Leaps by Bayer. The round also included participation by existing ...
-
Successful development and approval of Skinatan® 1 mg/g Emulsion – a new generic drug for the treatment of inflammations and allergic reactions
Skin Care Pharma GmbH, a company of Dermago Verwaltungs GmbH, announces that yet another milestone has been reached in the development and approval of Skinatan 1 mg/g Emulsion for cutaneous application with the active ingredient methylprednisolone aceponate (MPA). Upon receipt of the “End of Procedure” notification, the decentralized procedure (DCP) for Skinatan 1 mg/g Emulsion has ...
-
10 Reasons to Explore New Wound Closure Options for In-Office Procedures
Dermatologists may perform a number of in-office procedures that result in wounds, including biopsies and mole excisions. Traditional options for repairing these wounds include sutures, staples, adhesive strips, and other suture types. However, traditional wound care methods have several drawbacks, including cost, time, and patient limitations. New wound closure options, such as the microMend ...
-
New scientific paper published on the mechanism of action of Polyphenon E, a defined extract from green tea leaves, in preliminary stages of skin cancer
DERMAGO GmbH today announced the publication of an article by the research group of PD Dr. J. Eberle from Charité-Universitätsmedizin Berlin, Germany. The article entitled “Inhibition of Cell Proliferation and Cell Viability by Sinecatechins in Cutaneous SCC Cells Is Related to an Imbalance of ROS and Loss of Mitochondrial Membrane Potential” was released in the ...
-
Amsel Medical Announces Expanded Medical Advisor Group
Amsel Medical Corp. today announced the expansion of its medical advisory team as the company advances the current product commercialization phase to address the demand for minimally invasive, simple and secure occlusion. Joining the advisory team are - Col. John Dorsch, DO, USAF, Retired; prior wing surgeon, physician, and medical officer for the 24th Special Operations Wing (Air Force ...
-
Zerigo Health Expands Board of Directors
SAN DIEGO--(BUSINESS WIRE)--Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the appointments of Joseph E. Giles and Christina LaMontagne to the company’s Board of Directors. Both will serve as independent directors alongside Executive Chairman Glen Tullman, CEO John Schellhorn and investors ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you